BIOLOJIC DESIGN
Live / Applied — Non-final action written — not yet mailed (as of 15 Mar 2026)
What this means for you
Not registered yet, but its 30 Oct 2025 filing date beats anything filed after it. If it registers, the owner can stop confusingly similar uses in the classes it covers.
Record
- Serial number
- 79440971
- Mark type
- Design + words
- Filed
- 30 Oct 2025
Goods and services
- Class 005 — Pharmaceuticals: Antibodies for medical purposes; pharmaceutical preparations for use in the treatment of pulmonary, oncological, vascular, autoimmune, infectious, endocrinal, metabolic, cardiological and ocular diseases and disorders; pharmaceutical preparations for use in the treatment of edema; pharmaceutical preparations for use in immune suppression and for immune activation.
- Class 042 — Scientific and technological services: Drug discovery services; research and development services in the field of antibodies; product design and development in the field of antibodies and pharmaceuticals; biological research and analysis; computer aided scientific research in the fields of new drugs discovery and development, antibodies research, development and design, and antibody technology; pharmaceutical research and development; medical research
Owner
Prosecution history
- 16 Mar 2026 — NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW
- 15 Mar 2026 — NON-FINAL ACTION WRITTEN
- 13 Mar 2026 — ASSIGNED TO EXAMINER
- 10 Feb 2026 — APPLICATION FILING RECEIPT MAILED
- 10 Feb 2026 — NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
- 09 Feb 2026 — LIMITATION FROM ORIGINAL APPLICATION ENTERED
- 08 Jan 2026 — SN ASSIGNED FOR SECT 66A APPL FROM IB